TABLE 1.
CLSI group | Antimicrobial agent | % Agreement |
|||||||
---|---|---|---|---|---|---|---|---|---|
Automated AST |
Manual AST |
||||||||
Phoenix |
Vitek 2 |
MicroScan |
Etest |
||||||
EA | CA | EA | CA | EA | CA | EA | CA | ||
A | Penicillin | 90.7 | 95.5 | 91.8 | 94.2 | 95.8 | 98.7 | 96.1 | 97.7 |
Erythromycin | 92.0 | 99.7 | 94.2 | 97.3 | 96.8 | 99.7 | 97.1 | 100 | |
T/S | 92.6 | 98.1 | 92.4 | 97.9 | 96.1 | 97.7 | 96.1 | 98.4 | |
B | Cefepime | 95.5 | 99.7 | NAa | NA | 99.7 | 99.7 | NA | NA |
Cefotaxime | 94.5 | 100 | 97.9 | 100 | 99.0 | 100 | NA | NA | |
Ceftriaxone | 97.1 | 99.7 | 96.9 | 100 | 99.7 | 99.7 | 100 | 100 | |
Clindamycin | 90.4 | 100 | NA | NA | 98.4 | 99.4 | 95.5 | 100 | |
Levofloxacin | 96.5 | 100 | 94.8 | 100 | 100.0 | 100 | 100 | 100 | |
Meropenem | 94.2 | 98.4 | NA | NA | 98.7 | 99.4 | 98.4 | 99.7 | |
Tetracycline | 95.5 | 99.4 | 93.1 | 98.6 | 99.4 | 99.7 | NA | NA | |
Vancomycin | 100 | 100 | 98.3 | 100 | 100 | 100 | 100 | 100 | |
C | Linezolid | 98.4 | 100 | 95.9 | 100 | 100 | 100 | 100 | 100 |
O | Gatifloxacin | 100 | 100 | NA | NA | 100 | 100 | NA | NA |
NA, not applicable.